English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    O.L. Appelhans, К.М. Usychenko, Yu.I. Bazhora, О.M. Usychenko

    POLYMORPHISM OF SMAD7 (RS4939827) AND EIF3H (RS16892766) GENES AS A CRITERIUM OF FIBROSIS PROGRESSION RATE IN PATIENTS WITH CHRONIC HEPATITIS С AND В


    About the author: O.L. Appelhans, К.М. Usychenko, Yu.I. Bazhora, О.M. Usychenko
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation The purpose of the study was to assess the possibility of the relationship between the gene polymorphism of SMAD family member 7 (SMAD7C> T), the eukaryotic translation initiation factor (eIF3hC> A) and the degree of liver fibrosis in a pilot project in patients with chronic hepatitis B and chronic hepatitis C. Differences in the frequencies of alleles of the SMAD7 gene in the ethnically homogeneous group of residents of the Odessa region in patients with chronic hepatitis C and chronic hepatitis B compared to healthy individuals (p <0.05) were found. The presence of correlations was established: in patients with chronic hepatitis C, there is a direct weak correlation between the degree of fibrosis and SMAD7 genotypes (p <0.01); in patients with chronic hepatitis B, there is a direct strong correlation between the fibrosis degree and SMAD7 genotypes (p <0.01). The correlation between the degree of liver fibrosis and certain genotypes of SMAD7 in patients with chronic hepatitis C and chronic hepatitis B permits to use the information obtained as one of the criteria for the rate of fibrotic processes progression in the liver.
    Tags SMAD family member 7, eukaryotic translation initiation factor eIF3h, chronic hepatitis C, chronic hepatitis B
    Bibliography
    • Kalyuzhin OV, Ponezheva ZHB, Semenova IV, Khokhlova ON, Serebrovskaya LV, Guseva TS. i dr. Subpopulyatsii limfotsitov, uroven interferonov i ekspressiya ikh retseptorov u bolnykh khronicheskimi gepatitami V i S: zavisimost ot vida virusov i stepeni fibroza pecheni. Terapevticheskiy arkhiv. 2017; 89 (11): 14-20. doi:10.17116/terarkh2017891114-20 [in Russian]
    • Moroz LV, Yatsyk IV. Vplyv I/D polimorfizmu hena APF na tempy prohresuvannya khronichnoho hepatytu C. Hepatolohiya. 2013; 2:31-39. [in Ukrainian]
    • Rakhmanova AG, Yakovlev AA, Vinogradova YeN, Borisov AYe, Kashchenko VA; Rakhmanova AG. – redaktor. Khronicheskiye virusnyye gepatity i tsirroz pecheni: rukovodstvo dlya vrachey. 2016. SPb.: Spetslit. 413 s. [in Russian]
    • Svitich OA, Snegireva NA, Gankovskiy VA. Rol mikroRNK v mekhanizmakh immuniteta pri infektsionnoy patologii. Allergologiya i immunologiya. 2017; 18 (1): 19-24. [in Russian]
    • Faller DM Shilds D. Molekulyarnaya biologiya kletki: Rukovodstvo dlya vrachey. M.: BINOM-Press; 2017. 256 s. [in Russian]
    • Batool T, Fang J, Jansson V, Zhao H, Gallant C, Moustakas A, Li J. Upregulated BMP-Smad signaling activity in the glucuronyl C5-epimerase knock out MEF cells. Cell Signal. 2019; 54: 122-129. doi:10.1016/j.cellsig.2018.11.010. 
    • Davis H, Raja E, Miyazono K, Tsubakihara Y, Moustakas A. Mechanisms of action of bone morphogenetic proteins in cancer. Cytokine Growth Factor Rev. 2016; 27: 81-92. doi:10.1016/j.cytogfr.2015.11.009.
    • Feng T, Dzieran J, Yuan X, Dropmann A, Maass T, Teufel A et all. Hepatocyte-Specific SMAD7 Deletion Accelerates Den Induced Mouse Hepatocellular Carcinoma via Activation of STAT3 Signaling. Journal of Hepatology. 2016; 64(2): 572. doi: 10.1038/oncsis.2016.85
    • Ha M, Kim V. Regulation of microRNA biogenesis. Nature Reviews Molecular Cell. Biology. 2014; 15(8): 509-524. doi:10.1038/nrm3838
    • Huang Q, Zhang X, Bai F, Nie J, Wen S, Wei Y et all. Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways. Int Immunopharmacol. 2019; 66: 41-51. doi:10.1016/j.intimp.2018.11.006.
    • Macias MJ, Pau M, Massagué JM. Structural determinants of SMAD function in TGF-β signaling. Trends Biochem Sci. 2015; 40(6): 296–308. doi:10.1016/j.tibs.2015.03.012
    • Mashina R. Physiological roles of miR-155. Immunology. 2015; 145: 323–333 doi:10.1111/imm.12468
    • Moustakas A, Heldin P. TGFβ and matrix-regulated epithelial to mesenchymal transition. Biochim Biophys Acta. 2014; 1840(8):2621-2634. doi:10.1016/j.bbagen.2014.02.004. 
    • Sedano CD, Sarnow P. Interaction of host cell micronas with the HCV RNA genome during infection of liver cells. Semin. Liver Diseases. 2015; 35: 75-80. doi:10.1055/s-0034-1397351.
    • Thibault PA, Huys A, Amador-Cañizares Y, Gailius GE, Pinel DE, Wilson JA Regulation of hepatitis C virus genome replication by Xrn1 and microRNA – 122 binding to individual sites in the 5’ UTR. Journal virology. 2015; 89: 6294-6311. doi:10.1128/JVI.03631-14.
    Publication of the article «World of Medicine and Biology» №4(74), 2020 year, 7-10 pages, index UDK 616.36-002.2 575.174.015.3.
    DOI 10.26724/2079-8334-2020-4-74-7-10